Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
Stryker this week argued that the lawsuit it leveled against Zimmer Biomet this spring, accusing its orthopedics rival of poaching sales reps, doesn’t need to include the former reps.
Kalamazoo, Mich.-based Stryker sued Zimmer Biomet in March in the U.S. District Court for Southern Texas, alleging “concerted and deliberate unfair competition, improper use of Stryker’s confidential and trade secret information, and improper solicitations of Stryker’s customers and employees” in the Houston area. Read more
Pain mitigation company Calmare Therapeutics is facing an investor suit filed this week in New York federal court claiming the company made false statements and misled investors.
Investors in the suit are looking to recover millions of dollars of damages caused by the company’s’ alleged illegal conduct, citing violations of federal security laws and the dissemination of false and misleading statements to investors and the public. Read more
The recent WannaCry attack drew attention to ransomware vulnerabilities throughout healthcare systems, but ransomware itself is not the source cause of concern for the healthcare industry – legacy medical device software is, according to a new Healthcare IT News report.
The ransomware attack was merely a sign of possible future attacks, according to Healthcare IT News report authors healthcare cybersecurity company Virta Laboratories CEO Kevin Fu and Swansea University computer science professor Harold Thimbleby. Read more
Boston Scientific is reportedly set to put some $19 million (€17 million) into an R&D center for its endoscopy products in Galway, Ireland.
The Marlborough, Mass.-based company yesterday cut the ribbon on its RoadRunner facility, at a site it opened in 1994 that already employs 3,000 workers, according to news reports. The idea is to bring in about 300 physicians each year to provide feedback for engineers designing stents for the bowel or biliary tract. Read more
Mazor Robotics yesterday revealed a probe by Israel’s version of the U.S. Securities & Exchange Commission, sending share prices down today in early trading.
Caesarea, Israel-based Mazor said the Israeli Securities Authority searched its offices and questioned some members of management in May, “in connection with an investigation held by the ISA.” Read more